Strain Improvement Program of Streptomyces roseosporus for Daptomycin Production

Sara Rubio1, Sonia Martínez-Cámara1, Juan Luis de la Fuente1

  • 1Department of Biotechnology, Crystal Pharma, A Subsidiary of Albany Molecular Research Inc. (AMRI), Parque Tecnológico de León, León, Spain.

Summary

This study enhances daptomycin production by improving Streptomyces roseosporus strains through mutagenesis and screening. The goal is to achieve higher yields for more cost-effective antibiotic manufacturing.

Related Concept Videos